Barclays Maintains Overweight on Intuitive Surgical, Raises Price Target to $430
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Matt Miksic has maintained an Overweight rating on Intuitive Surgical (NASDAQ:ISRG) and increased the price target from $385 to $430, indicating a positive outlook on the company's stock.
January 25, 2024 | 12:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst Matt Miksic maintains an Overweight rating on Intuitive Surgical and raises the price target from $385 to $430, suggesting a bullish stance on the stock.
The increase in price target by a reputable analyst typically signals confidence in the company's future performance and can lead to a positive investor sentiment, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100